<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
    <front>
        <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id><journal-id journal-id-type="pmc">ploscomp</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Computational Biology</journal-title></journal-title-group><issn pub-type="ppub">1553-734X</issn><issn pub-type="epub">1553-7358</issn><publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, USA</publisher-loc>
            </publisher></journal-meta>
        <article-meta><article-id pub-id-type="publisher-id">08-PLCB-RA-0362R3</article-id><article-id pub-id-type="doi">10.1371/journal.pcbi.1000399</article-id><article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline">
                    <subject>Immunology/Immune Response</subject>
                    <subject>Immunology/Immunity to Infections</subject>
                    <subject>Immunology/Innate Immunity</subject>
                    <subject>Infectious Diseases/Epidemiology and Control of Infectious Diseases</subject>
                    <subject>Mathematics</subject>
                    <subject>Public Health and Epidemiology/Infectious Diseases</subject>
                </subj-group>
            </article-categories><title-group><article-title>The Effect of Ongoing Exposure Dynamics in Dose Response
                    Relationships</article-title><alt-title alt-title-type="running-head">Infectious Dose Timing Effects</alt-title></title-group><contrib-group>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Pujol</surname>
                        <given-names>Josep M.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff1">
                        <sup>1</sup>
                    </xref>
                    <xref ref-type="aff" rid="aff2">
                        <sup>2</sup>
                    </xref>
                    <xref ref-type="corresp" rid="cor1">
                        <sup>*</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Eisenberg</surname>
                        <given-names>Joseph E.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff1">
                        <sup>1</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Haas</surname>
                        <given-names>Charles N.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff3">
                        <sup>3</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Koopman</surname>
                        <given-names>James S.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff1">
                        <sup>1</sup>
                    </xref>
                </contrib>
            </contrib-group><aff id="aff1">
                <label>1</label>
                <addr-line>Department of Epidemiology, University of Michigan, Ann Arbor, Michigan,
                    United States of America</addr-line>
            </aff><aff id="aff2">
                <label>2</label>
                <addr-line>Center for the Study of Complex Systems, University of Michigan, Ann
                    Arbor, Michigan, United States of America</addr-line>
            </aff><aff id="aff3">
                <label>3</label>
                <addr-line>Department of Civil, Architectural and Environmental Engineering, Drexel
                    University, Philadelphia, Pennsylvania, United States of America</addr-line>
            </aff><contrib-group>
                <contrib contrib-type="editor" xlink:type="simple">
                    <name name-style="western">
                        <surname>Antia</surname>
                        <given-names>Rustom</given-names>
                    </name>
                    <role>Editor</role>
                    <xref ref-type="aff" rid="edit1"/>
                </contrib>
            </contrib-group><aff id="edit1">Emory University, United States of America</aff><author-notes>
                <corresp id="cor1">* E-mail: <email xlink:type="simple">jmpujol@umich.edu</email></corresp>
                <fn fn-type="con">
                    <p>Conceived and designed the experiments: JMP JEE CNH JSK. Performed the
                        experiments: JMP JEE JSK. Analyzed the data: JMP JEE JSK. Contributed
                        reagents/materials/analysis tools: JMP JEE JSK. Wrote the paper: JMP JEE
                        JSK.</p>
                </fn>
            <fn fn-type="conflict">
                <p>The authors have declared that no competing interests exist.</p>
            </fn></author-notes><pub-date pub-type="collection">
                <month>6</month>
                <year>2009</year>
            </pub-date><pub-date pub-type="epub">
                <day>5</day>
                <month>6</month>
                <year>2009</year>
            </pub-date><volume>5</volume><issue>6</issue><elocation-id>e1000399</elocation-id><history>
                <date date-type="received">
                    <day>7</day>
                    <month>7</month>
                    <year>2008</year>
                </date>
                <date date-type="accepted">
                    <day>4</day>
                    <month>5</month>
                    <year>2009</year>
                </date>
            </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2009</copyright-year><copyright-holder>Pujol et al</copyright-holder><license><license-p>This is an open-access article distributed under the
                terms of the Creative Commons Attribution License, which permits unrestricted use,
                distribution, and reproduction in any medium, provided the original author and
                source are credited.</license-p></license></permissions><abstract>
                <p>Characterizing infectivity as a function of pathogen dose is integral to
                    microbial risk assessment. Dose-response experiments usually administer doses to
                    subjects at one time. Phenomenological models of the resulting data, such as the
                    exponential and the Beta-Poisson models, ignore dose timing and assume
                    independent risks from each pathogen. Real world exposure to pathogens, however,
                    is a sequence of discrete events where concurrent or prior pathogen arrival
                    affects the capacity of immune effectors to engage and kill newly arriving
                    pathogens. We model immune effector and pathogen interactions during the period
                    before infection becomes established in order to capture the dynamics generating
                    dose timing effects. Model analysis reveals an inverse relationship between the
                    time over which exposures accumulate and the risk of infection. Data from one
                    time dose experiments will thus overestimate per pathogen infection risks of
                    real world exposures. For instance, fitting our model to one time dosing data
                    reveals a risk of 0.66 from 313 <italic>Cryptosporidium parvum</italic>
                    pathogens. When the temporal exposure window is increased 100-fold using the
                    same parameters fitted by our model to the one time dose data, the risk of
                    infection is reduced to 0.09. Confirmation of this risk prediction requires data
                    from experiments administering doses with different timings. Our model
                    demonstrates that dose timing could markedly alter the risks generated by
                    airborne versus fomite transmitted pathogens.</p>
            </abstract><abstract abstract-type="summary">
                <title>Author Summary</title>
                <p>We model the relationship between the temporal patterns of pathogen exposure and
                    infection take off within people. Since different routes of transmission (e.g.,
                    airborne versus surface transfer routes) may result in different temporal
                    patterns of exposure, this model helps to better compare the risks of
                    transmission from one person to another through these different routes. Previous
                    models assumed that the risk of infection is the same whether pathogens are
                    inoculated all at once or over one day. Our model, in contrast, captures how one
                    pathogen affects the potential of immunity to keep concurrently or subsequently
                    arriving particles from initiating an infection. Since the pattern of timing of
                    airborne and surface spread pathogen arrivals differ, our model shows that each
                    airborne pathogen could carry less risk than each surface transmitted pathogen.
                    Unfortunately, data to fully fit our model are not currently available.
                    Therefore new experiments will have to be conducted where doses are given across
                    different temporal windows.</p>
            </abstract><funding-group><funding-statement>This research was supported by U.S. EPA: Science to Achieve Results (STAR)
                    Program and by U.S. Department of Homeland Security University Programs (Grant #
                    R83236201). The funders had no role in study design, data collection and
                    analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
                <page-count count="12"/>
            </counts></article-meta>
    </front>
    <body>
        <sec id="s1">
            <title>Introduction</title>
            <p>Microbial risk assessment models are valuable tools for estimating the risks
                associated with exposures to pathogens in the environment pathogens <xref ref-type="bibr" rid="pcbi.1000399-Haas1">[1]</xref>. Central
                to this estimate is a dose-response model that predicts the probability of infection
                given a dose exposure magnitude. In current microbial risk assessment models dose
                accumulates over time and the probability of infection is based on the total
                accumulated dose over that period of time <xref ref-type="bibr" rid="pcbi.1000399-Noakes1">[2]</xref>–<xref ref-type="bibr" rid="pcbi.1000399-Atkinson1">[4]</xref>. This
                assumes that each pathogen particle carries a risk of infection that is independent
                of when other pathogens have arrived to a host; i.e., three exposures to dose X
                generate the same total risk as one exposure to a 3× dose. We put forth an
                alternative dose response model that assumes the current capacity of immune
                effectors to control an arriving pathogen should be affected by 1) how many
                effectors are occupied fighting previously or simultaneously arriving pathogens, 2)
                how many effectors have been depleted in fighting previously arriving pathogens, and
                3) how many effector reinforcements have arrived due to usual effector turnover
                rates or due to a stimulus from prior pathogen exposure.</p>
            <p>If dose-timing effects arise from such immune effector dynamics, then infection-risk
                calculations that do not take these dose-timing effects into account could lead to
                errors. For example, errors could arise in models of influenza transmission as
                follows. Pathogens arriving to a host via aerosols do so more frequently but at
                lower doses than pathogens arriving via hand or fomite mediated inoculations. Models
                of influenza transmission that do not account for dose-timing effects, such as the
                model by Atkinson and Wien <xref ref-type="bibr" rid="pcbi.1000399-Atkinson1">[4]</xref>, might misdirect influenza control resources to
                masks from hand hygiene. Models that assume independent single dose effects will
                require more extreme cleaning to reduce risks to acceptable levels than models
                capturing immune effects on dose timing.</p>
            <p>Evaluating the potential importance of such dose-timing effects is difficult for two
                reasons. First, immune control of pathogens is complex; not enough detailed
                knowledge regarding that complexity is available to provide a high degree of
                confidence in a-priori causal model predictions. Second, there is almost no direct
                observational data documenting the presence or absence of dose-timing effects.
                Although various studies have given pathogen exposure doses over time <xref ref-type="bibr" rid="pcbi.1000399-Ellenberger1">[5]</xref>–<xref ref-type="bibr" rid="pcbi.1000399-Wilson1">[10]</xref>, only Brachman et al.
                    <xref ref-type="bibr" rid="pcbi.1000399-Brachman1">[11]</xref>, has been conducted in a manner that allows one to
                calculate risks for comparable doses administered over different temporal windows.</p>
            <p>In this paper we have taken an approach intended to stimulate science that will
                address both of these issues. We develop a simple model that illustrates the need to
                generate new data that can describe dose-timing effects while at the same time
                providing a base upon which to build more realistic models that incorporate more
                data and theory on immunity. Our model addresses immune control of pathogens between
                the time pathogens arrive at a host and the time they are either eliminated or have
                multiplied enough so that an acquired immune response will be needed for control.</p>
            <p>We make our model general enough to capture dynamics of pathogen control that might
                arise from established antibodies and T-cells, macrophages, polymorphonuclear
                leukocytes, plasma cells, dendritic cells, complement cascades, chemokines,
                interleukins, interferons, toll like receptors, and other diverse elements affecting
                immunity. But we lump all these mediators of pathogen control into a highly abstract
                entity we label as immune effectors. We assume that the dynamic effects of limited
                immune effector numbers are similar whether the limitation arises from immune
                effectors being occupied with previously arrived pathogens or from prior consumption
                of immune effectors in their process of killing pathogens. Therefore we only model
                the latter source of immune effector limitations. The resulting model is one where
                any single pathogen always has some chance of initiating an infection but the risk
                of infection associated with each additional pathogen exposure can markedly increase
                at higher pathogen doses given over short temporal windows. The exact dynamics of
                our model will vary as realistic details are added to it. Our goal here is simply to
                illustrate the importance and inevitability of immune mediated dose-timing effects
                so as to stimulate further empirical and theoretical work.</p>
            <p>The structure of the paper is as follows: in the <xref ref-type="sec" rid="s2">methods</xref> section we describe the
                Cumulative Dose model and analyze its dynamics. In the <xref ref-type="sec" rid="s3">results</xref> section we use the
                Cumulative Dose model to fit experimental data assuming a fixed temporal exposure
                window to simulate the archetypical single dose experiment of dose-response trials.
                Using the estimated model we show the effect of changing the length of the temporal
                exposure window. Finally, the conclusions and future research are presented in the
                <xref ref-type="sec" rid="s4">discussion</xref> section.</p>
        </sec>
        <sec id="s2">
            <title>Methods</title>
            <sec id="s2a">
                <title>Cumulative Dose Model</title>
                <p>The model is based on a stochastic population of individual pathogens and immune
                    effectors. Since the focus of our analysis is how small populations of pathogens
                    either die out or lead to infection initiation, we cannot rely on the mean-field
                    solution provided by the deterministic framework <xref ref-type="bibr" rid="pcbi.1000399-Rand1">[12]</xref>–<xref ref-type="bibr" rid="pcbi.1000399-Alonso1">[14]</xref>.</p>
                <p>The state of the system is defined by the pair (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e001" xlink:type="simple"/></inline-formula>) representing the number of immune effectors and the number of
                    pathogens, in any single host, respectively. The system is defined by the
                    following set of state transitions:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e002" xlink:type="simple"/><label>(1)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e003" xlink:type="simple"/><label>(2)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e004" xlink:type="simple"/><label>(3)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e005" xlink:type="simple"/><label>(4)</label></disp-formula></p>
                <p>The number of immune effectors <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e006" xlink:type="simple"/></inline-formula> can increase at: 1) a rate <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e007" xlink:type="simple"/></inline-formula>, which models the constant arrival of immune effectors
                    regardless of the current state of the immunological system; and 2) a rate <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e008" xlink:type="simple"/></inline-formula>, which models the recruitment of immune effectors in the
                    presence of pathogens. This term is intended to reflect cytokine induced
                    recruitment of remote immune effectors to a pathogen invasion site and not
                    acquired immunity. We assume that the relative endpoints of infection takeoff or
                    pathogen elimination are reached before an acquired immune effect comes into
                    play. Immune effectors decrease either at a natural death rate <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e009" xlink:type="simple"/></inline-formula>, or at a mass-action deactivation rate due to the encounter
                    with pathogens <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e010" xlink:type="simple"/></inline-formula>.</p>
                <p>The number of pathogens <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e011" xlink:type="simple"/></inline-formula> can increase by reproduction at a rate <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e012" xlink:type="simple"/></inline-formula> or by arrival during the inoculation period at a rate <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e013" xlink:type="simple"/></inline-formula>. Here <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e014" xlink:type="simple"/></inline-formula> represents the net reproduction rate that aggregates birth and
                    death rates. Pathogen numbers decrease due to interaction with immune effectors
                    as a mass-action deactivation process at the rate <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e015" xlink:type="simple"/></inline-formula>.</p>
            </sec>
            <sec id="s2b">
                <title>Dynamics of the Cumulative Dose Model</title>
                <p>The initial state of the system is set to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e016" xlink:type="simple"/></inline-formula>. No chronic low-level exposures or remaining pathogens from
                    prior exposures are considered. The system starts from the clean state: no
                    pathogens and the stationary number of immune effectors in the absence of
                    pathogens. The inoculation process is characterized by the dose of exposure <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e017" xlink:type="simple"/></inline-formula> and the temporal exposure length <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e018" xlink:type="simple"/></inline-formula>; i.e., the dose that is composed by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e019" xlink:type="simple"/></inline-formula> pathogens is inoculated into the host during a period of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e020" xlink:type="simple"/></inline-formula> time units. Therefore, the arrival of external pathogens is
                    modeled as the rate <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e021" xlink:type="simple"/></inline-formula> during the inoculation period. Once inoculation has finished
                    the pathogen arrival rate becomes zero. Thus, the rate <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e022" xlink:type="simple"/></inline-formula> depends on time and is defined as<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e023" xlink:type="simple"/></disp-formula></p>
                <p>During <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e024" xlink:type="simple"/></inline-formula>, the pathogens, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e025" xlink:type="simple"/></inline-formula> arrive over a continuous time in the presence of the
                    immunological response to those pathogens. Once the inoculation has finished,
                    only the immunological response remains. We set the unit of time to an hour.
                    That keeps us in the range where we think exposure fluctuations are making a
                    difference and out of the range where adaptive immune system feedbacks come into
                    play.</p>
                <p>Due to stochastic effects and the fate of a relatively small population of
                    pathogens and immune effectors, the same inoculation dose <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e026" xlink:type="simple"/></inline-formula> administered in the same time frame <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e027" xlink:type="simple"/></inline-formula> does not necessarily have the same outcome. Each replication
                    (i.e. run) of the model corresponds to a dose trial on a new subject. All the
                    numerical results are the average of 10<sup>4</sup> runs of the Cumulative Dose
                    model implemented with the Gillespie algorithm <xref ref-type="bibr" rid="pcbi.1000399-Gillespie1">[15]</xref> using
                    <italic>C</italic>. The criteria to stop the simulation is either extinction of
                    pathogens after the inoculation period (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e028" xlink:type="simple"/></inline-formula>) or pathogens diverging to a very large number, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e029" xlink:type="simple"/></inline-formula>, corresponding to no infection and infection respectively. The
                    probability of infection for a pair <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e030" xlink:type="simple"/></inline-formula> is the proportion of simulations that diverge to a large
                    number as opposed to equilibrating to the state of no pathogens.</p>
                <p><xref ref-type="fig" rid="pcbi-1000399-g001">Figure 1</xref> illustrates the
                    stochastic process effects on pathogen dynamics given a fixed time of exposure
                    for different inoculation doses. The main plot in this figure is the time course
                    of the number of pathogens for 100 independent dose trials given a dose of 60
                    pathogens administered over one unit of time. The number of pathogens steadily
                    grow during the inoculation period, from 0 to 1, since the rate of arrival of
                    pathogens (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e031" xlink:type="simple"/></inline-formula>) is much faster than immunological killing of pathogens. Once
                    the entire dose has been inoculated at
                    time = 1, the external arrival of pathogens
                    stop (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e032" xlink:type="simple"/></inline-formula>) and the immunological response dominates the rest of the
                    dynamics. In this particular case, the population of pathogens becomes extinct
                    in 33 cases out of 100, thus, the probability of infection given a dose of 60
                    pathogens over 1 unit of time is 0.67. Analogously, for a dose of 25 the
                    probability of infection is 0.02 and for a dose of 90 the probability of
                    infection is 0.98 (insets of <xref ref-type="fig" rid="pcbi-1000399-g001">Figure
                        1</xref>).</p>
                <fig id="pcbi-1000399-g001" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pcbi.1000399.g001</object-id>
                    <label>Figure 1</label>
                    <caption>
                        <title>Evolution of the number of pathogens over time for a characteristic
                            parameter set <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e033" xlink:type="simple"/></inline-formula>.</title>
                        <p>Each line represents an individual replicate with the same parameter set
                            (100 in total). The fraction of replicates in which the number of
                            pathogens diverge towards infinity, as opposed to going extinct, is
                            equivalent to the probability of infection
                            (<italic>p<sub>inf</sub></italic>) for the dose <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e034" xlink:type="simple"/></inline-formula> (main graph, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e035" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e036" xlink:type="simple"/></inline-formula> for the insets a) and b) respectively). Temporal
                            exposure length is fixed at
                            <italic>T<sub>e</sub></italic> = 1
                            hour. Probability of infection is 0.67, 0.02 and 0.98 for the main
                            graph, the inset a), and the inset b) respectively.</p>
                    </caption>
                    <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.g001" xlink:type="simple"/>
                </fig>
            </sec>
            <sec id="s2c">
                <title>Temporal Exposure Length</title>
                <p><xref ref-type="fig" rid="pcbi-1000399-g001">Figure 1</xref> illustrates how the
                    Cumulative Dose model yields higher probability of infection when the inoculated
                    dose is increased. The length of time over which the dose is administered, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e037" xlink:type="simple"/></inline-formula>, also plays a crucial role in the probability of infection. At
                    one extreme where all the pathogens were inoculated at once (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e038" xlink:type="simple"/></inline-formula>), the immune system has no time to react, and the initial
                    state of the system is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e039" xlink:type="simple"/></inline-formula>. From this initial state, the immunological response dynamics
                    determines the fate of the pathogens: either extinction or unbounded growth of
                    pathogens diverging towards infinity.</p>
                <p>For <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e040" xlink:type="simple"/></inline-formula>, however, the initial state after all pathogens have been
                    inoculated (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e041" xlink:type="simple"/></inline-formula>) is not the expected <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e042" xlink:type="simple"/></inline-formula>, but rather a distribution of probabilities over the space of
                    possible states. <xref ref-type="fig" rid="pcbi-1000399-g002">Figure 2</xref>
                    shows the stochastically determined distribution of system states at the point
                    in <xref ref-type="fig" rid="pcbi-1000399-g001">Figure 1</xref> where the
                    exposure time has just ended. It illustrates the effect of different temporal
                    exposure lengths, ranging from <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e043" xlink:type="simple"/></inline-formula> (six minutes) to
                    <italic>T<sub>e</sub></italic> = 50 hours.
                    Panel B shows this point of time for the settings in <xref ref-type="fig" rid="pcbi-1000399-g001">Figure 1</xref>. The longer the exposure length, the
                    larger will be the variance in the distribution of probabilities. Furthermore, a
                    longer exposure length also affects the average state after inoculation. Both
                    the pathogen levels and the immune effector levels decrease from the
                    instantaneous inoculation values as the exposure window length increases. But
                    the balance between these increasingly favors the immune effectors. Longer
                    temporal exposure lengths dilute the arrival rate of external pathogens, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e044" xlink:type="simple"/></inline-formula>. Consequently the immunological response has more time to
                    neutralize the existing pathogens before the arrival of new pathogens. On the
                    other hand, as the temporal exposure lengths decrease, an increased number of
                    immune effectors are consumed in killing pathogens, leading to a higher
                    probability of unbounded growth of pathogens, and thus infection.</p>
                <fig id="pcbi-1000399-g002" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pcbi.1000399.g002</object-id>
                    <label>Figure 2</label>
                    <caption>
                        <title>State probability distribution at the end of inoculation (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e045" xlink:type="simple"/></inline-formula>) for a dose of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e046" xlink:type="simple"/></inline-formula> and temporal exposure length of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e047" xlink:type="simple"/></inline-formula>) 0.1 h, B) 1.0 h, C) 10.0 h and D) 50.0 h.</title>
                        <p>The distribution of probabilities if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e048" xlink:type="simple"/></inline-formula> would be <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e049" xlink:type="simple"/></inline-formula> given the parameters of the system are <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e050" xlink:type="simple"/></inline-formula>. The dashed white line is the separatrix of the
                            deterministic version of the model (see subsection Deterministic
                            Analysis); if the system were deterministic once inoculation has been
                            completed, the states that fall below the separatrix would end up in no
                            infection, and the states above would end up in infection.</p>
                    </caption>
                    <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.g002" xlink:type="simple"/>
                </fig>
                <p>For <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e051" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e052" xlink:type="simple"/></inline-formula> the average state after inoculation is very close to the ideal
                    instantaneous inoculation, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e053" xlink:type="simple"/></inline-formula>. To better understand the dynamics once inoculation is over,
                    we included the numerically calculated separatrix as if the system were
                    deterministic (red-dashed line in <xref ref-type="fig" rid="pcbi-1000399-g002">Figure 2</xref>). Although this separatrix is only truly valid for the
                    analogous deterministic model, it indicates the probable fate of different
                    initial states. For the deterministic system, the separatrix separates those
                    states that go to infection from those that do not (see subsection on
                    Deterministic Analysis). As temporal exposure length increases, the distribution
                    of probabilities gravitates towards the space of states that go to no-infection
                    (below the separatrix).</p>
            </sec>
            <sec id="s2d">
                <title>Deterministic Analysis</title>
                <p>Further understanding of the stochastic dynamics of the Cumulative Dose model can
                    come from a deterministic description of the system that assumes a continuous
                    large number of immune effectors and pathogens. We focus our analysis on the
                    dynamics after the inoculation period, so <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e054" xlink:type="simple"/></inline-formula> is set to 0 and removed from the equations. This analysis on
                    the deterministic version helps illustrate the interactions between pathogens
                    and immune effectors that result either in infection or extinction of pathogens.</p>
                <p>The stochastic system is fully described by a multivariate master equation <xref ref-type="bibr" rid="pcbi.1000399-vanKampen1">[16]</xref>,
                    which can be expanded in a deterministic formulation known as
                        <italic>macroscopic law</italic>. The deterministic version of the
                    cumulative dose model is as follows,<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e055" xlink:type="simple"/><label>(5)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e056" xlink:type="simple"/><label>(6)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e057" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e058" xlink:type="simple"/></inline-formula> are continuous variables of the population of pathogens and
                    immune effectors respectively. The fixed points of the deterministic version of
                    the cumulative dose model are <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e059" xlink:type="simple"/></inline-formula>where the pathogen has been eliminated and immune effectors are
                    in equilibrium and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e060" xlink:type="simple"/></inline-formula> where the forces of pathogen growth are balanced by immune
                    dynamics affecting pathogen death. Note that in the stochastic analyses of this
                    model as in <xref ref-type="fig" rid="pcbi-1000399-g001">Figure 1</xref>, this
                    point is never reached. Instead simulations are terminated when growth takes off
                    toward this point. A simple analysis of the stability of the fixed points
                    reveals the space of parameters in which the solution is well-defined.</p>
                <p>The point <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e061" xlink:type="simple"/></inline-formula> is the equilibrium of no infection—the equilibrium
                    of the system in the absence of pathogens. When the system gravitates towards <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e062" xlink:type="simple"/></inline-formula> the immunological system prevents pathogens from growing,
                    resulting in pathogen extinction and therefore no infection.</p>
                <p>To evaluate the stability of the fixed point, we formulate the Jacobian matrix of
                    the system of equations on <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e063" xlink:type="simple"/></inline-formula>.<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e064" xlink:type="simple"/><label>(7)</label></disp-formula></p>
                <p>For a stable equilibrium, both Eigenvalues of the Jacobian matrix need to be
                    negative, or equivalently, the matrix must have a negative trace and a positive
                    determinant. For the trace of the Jacobian to be negative the condition <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e065" xlink:type="simple"/></inline-formula> must be true. Since the positive determinant condition, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e066" xlink:type="simple"/></inline-formula>, is more restrictive it subsumes the condition for a negative
                    trace.</p>
                <p>The second fixed point <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e067" xlink:type="simple"/></inline-formula> is only well-defined when both <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e068" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e069" xlink:type="simple"/></inline-formula> are positive, since negative number of pathogens and immune
                    effectors are impossible. The number of pathogens is only positive when <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e070" xlink:type="simple"/></inline-formula>. Given the condition of a positive determinant, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e071" xlink:type="simple"/></inline-formula>, the sign can only be negative, consequently <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e072" xlink:type="simple"/></inline-formula>. Therefore, the system is well defined — i.e. has a
                    stable equilibrium at no infection and with both fixed points in the positive
                    quadrant — only when the following condition 8 is met<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e073" xlink:type="simple"/><label>(8)</label></disp-formula></p>
                <p>Once we determine the stability of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e074" xlink:type="simple"/></inline-formula> we need to characterize the second fixed point <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e075" xlink:type="simple"/></inline-formula>. After some basic algebra, the determinant of the Jacobian
                    matrix for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e076" xlink:type="simple"/></inline-formula> can be expressed as follows: <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e077" xlink:type="simple"/></inline-formula>. Given condition 8, both terms are positive, which makes the
                    determinant negative. As a result the Eigenvalues of the Jacobian are real with
                    different signs. Therefore, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e078" xlink:type="simple"/></inline-formula> is a saddle point as shown in <xref ref-type="fig" rid="pcbi-1000399-g003">Figure 3</xref>.</p>
                <fig id="pcbi-1000399-g003" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pcbi.1000399.g003</object-id>
                    <label>Figure 3</label>
                    <caption>
                        <title>Vector field plot of the deterministic cumulative dose model for a
                            characteristic parameter set <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e079" xlink:type="simple"/></inline-formula>.</title>
                        <p>To avoid overlaps of the vectors they have been normalized. The solid red
                            lines are the nullclines, the intersections of the nullclines are the
                            fixed points <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e080" xlink:type="simple"/></inline-formula> (stable pathogen elimination equilibrium) and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e081" xlink:type="simple"/></inline-formula> (unstable saddle point equilibrium). The dash black
                            line is the separatrix that separates those configurations that will go
                            to non-infection equilibrium, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e082" xlink:type="simple"/></inline-formula>, and those that will diverge in the number of
                            pathogens resulting on infection. The separatrix has been calculated
                            numerically.</p>
                    </caption>
                    <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.g003" xlink:type="simple"/>
                </fig>
                <p>The vector field in <xref ref-type="fig" rid="pcbi-1000399-g003">Figure 3</xref>
                    illustrates the dynamics of the cumulative dose after the inoculation period.
                    The probability of being in a given state after inoculation is shown in <xref ref-type="fig" rid="pcbi-1000399-g002">Figure 2</xref>. If the system were
                    deterministic then we could anticipate the probability of infection by summing
                    the probability of those states below the separatrix. This does not hold for the
                    stochastic Cumulative Dose model. Nonetheless, the deterministic vector field,
                    shown in <xref ref-type="fig" rid="pcbi-1000399-g003">Figure 3</xref>, serves as
                    an approximate description of what happens in the stochastic model.</p>
                <p>For instance, let us take the probability distribution of states when centered at <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e083" xlink:type="simple"/></inline-formula>, i.e., <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e084" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e085" xlink:type="simple"/></inline-formula>. The typical dynamic results in the decrease in number of
                    pathogens and immune effectors, gravitating towards the saddle point <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e086" xlink:type="simple"/></inline-formula>, from which it will bifurcate to the stable point of
                    no-infection <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e087" xlink:type="simple"/></inline-formula>, or an unbounded growth of pathogens. In the case of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e088" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e089" xlink:type="simple"/></inline-formula>, most of the states are already very low in pathogens, and
                    consequently the number of immune effectors will eradicate the few pathogens
                    still existing and go to the stable equilibrium of no infection. However, there
                    is a non-zero probability, albeit small, of being in a state with a large number
                    of pathogens and a small number of immune effectors. In this case, stochastic
                    perturbations aside, the pathogens will keep multiplying producing infection in
                    the host.</p>
            </sec>
        </sec>
        <sec id="s3">
            <title>Results</title>
            <sec id="s3a">
                <title>Analysis of Exposure Dose Risks</title>
                <p>In this section, we fit empirical data on multiple pathogens for the single event
                    inoculation scenario. Next, we extend our analysis to incorporate different
                    temporal exposure windows and patterns of inoculation.</p>
                <sec id="s3a1">
                    <title>Fitting experimental dose-response data</title>
                    <p>We selected three different pathogen datasets: 1) poliovirus <xref ref-type="bibr" rid="pcbi.1000399-Minor1">[17]</xref>,
                        2) <italic>Cryptosporidium parvum</italic>
                        <xref ref-type="bibr" rid="pcbi.1000399-DuPont1">[18]</xref> and 3) rotavirus <xref ref-type="bibr" rid="pcbi.1000399-Ward1">[19]</xref>. Analyses of
                        these three datasets are found elsewhere <xref ref-type="bibr" rid="pcbi.1000399-Teunis1">[20]</xref>.</p>
                    <p>Several statistical models based on the empirical data have been proposed to
                        describe dose-response data. The most common models are the Exponential
                        model <xref ref-type="bibr" rid="pcbi.1000399-Haas1">[1]</xref>:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e090" xlink:type="simple"/><label>(9)</label></disp-formula>where <italic>μ</italic> is the inoculation dose and
                            <italic>r</italic> is the per pathogen risk, and the Beta-Poisson model
                            <xref ref-type="bibr" rid="pcbi.1000399-Haas2">[21]</xref>:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e091" xlink:type="simple"/><label>(10)</label></disp-formula>where <italic>μ</italic> is the inoculation dose and
                            <italic>α</italic> and <italic>β</italic> are parameters
                        of the beta distribution that describes the host pathogen interaction. Other
                        models such as Log-Logistic and Weibull have been used, but not as commonly.</p>
                    <p>For parameter estimation we used a classical genetic algorithm <xref ref-type="bibr" rid="pcbi.1000399-Holland1">[22]</xref>. The fitness function of the genetic
                        algorithm was the mean square error (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e092" xlink:type="simple"/></inline-formula>). We fixed the exposure time (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e093" xlink:type="simple"/></inline-formula>) of our inoculated dose (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e094" xlink:type="simple"/></inline-formula>) to 1.0 time units in order to emulate the empirical
                        dose-response experiments in which the dose is inoculated in a single shot;
                        i.e., a very short exposure. We present the best fitting curves and discuss
                        their limitations in the subsection “The Effect of Temporal
                        Exposure Length”. Then, given these best fitting parameter values,
                        we present the effect of different temporal exposure windows on the final
                        probability of infection.</p>
                </sec>
            </sec>
            <sec id="s3b">
                <title>Poliovirus</title>
                <p>The first empirical dataset to which we apply the Cumulative Dose model is
                    Poliovirus type 1 <xref ref-type="bibr" rid="pcbi.1000399-Minor1">[17]</xref>. The cohort for this experiment was 32
                    2-month-old infants. Inoculation was oral. <xref ref-type="fig" rid="pcbi-1000399-g004">Figure 4</xref> and <xref ref-type="table" rid="pcbi-1000399-t001">Table 1</xref> show the fit alongside a fit to the
                    Exponential model (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e095" xlink:type="simple"/></inline-formula>) according to <xref ref-type="bibr" rid="pcbi.1000399-DuPont1">[18]</xref>.</p>
                <fig id="pcbi-1000399-g004" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pcbi.1000399.g004</object-id>
                    <label>Figure 4</label>
                    <caption>
                        <title>Dose-response curves based on the Exponential Model (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e096" xlink:type="simple"/></inline-formula>) and the Cumulative Dose model (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e097" xlink:type="simple"/></inline-formula>) compared to the experimental dataset for Poliovirus
                            type 1 (squares).</title>
                        <p>The estimated parameters are <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e098" xlink:type="simple"/></inline-formula> for the Exponential model <xref ref-type="bibr" rid="pcbi.1000399-Eisenberg1">[3]</xref> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e099" xlink:type="simple"/></inline-formula> for the Cumulative Dose model.</p>
                    </caption>
                    <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.g004" xlink:type="simple"/>
                </fig>
                <table-wrap id="pcbi-1000399-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000399.t001</object-id><label>Table 1</label><caption>
                        <title>Probability of infection from experimental data for Polivirus type 1 (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e100" xlink:type="simple"/></inline-formula>) compared to the probability of infection based on the
                            Exponential model (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e101" xlink:type="simple"/></inline-formula>) and the Cumulative Dose model (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e102" xlink:type="simple"/></inline-formula>).</title>
                    </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pcbi-1000399-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.t001" xlink:type="simple"/><table>
                        <colgroup span="1">
                            <col align="left" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                        </colgroup>
                        <thead>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">Dose</td>
                                <td align="left" colspan="1" rowspan="1">No. of subjects</td>
                                <td align="left" colspan="1" rowspan="1">No. Infected</td>
                                <td align="left" colspan="1" rowspan="1">Fraction Infected <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e103" xlink:type="simple"/></inline-formula></td>
                                <td align="left" colspan="1" rowspan="1">
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e104" xlink:type="simple"/></inline-formula>
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e105" xlink:type="simple"/></inline-formula>
                                </td>
                                <td align="left" colspan="1" rowspan="1">
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e106" xlink:type="simple"/></inline-formula>
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e107" xlink:type="simple"/></inline-formula>
                                </td>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">
                                    <bold>7.0</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">0</td>
                                <td align="left" colspan="1" rowspan="1">0.0</td>
                                <td align="left" colspan="1" rowspan="1">0.0617</td>
                                <td align="left" colspan="1" rowspan="1">0.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">
                                    <bold>16.0</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1">2</td>
                                <td align="left" colspan="1" rowspan="1">0</td>
                                <td align="left" colspan="1" rowspan="1">0.0</td>
                                <td align="left" colspan="1" rowspan="1">0.1355</td>
                                <td align="left" colspan="1" rowspan="1">0.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">
                                    <bold>27.0</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1">2</td>
                                <td align="left" colspan="1" rowspan="1">0</td>
                                <td align="left" colspan="1" rowspan="1">0.0</td>
                                <td align="left" colspan="1" rowspan="1">0.2178</td>
                                <td align="left" colspan="1" rowspan="1">0.0062</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">
                                    <bold>42.0</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">0</td>
                                <td align="left" colspan="1" rowspan="1">0.0</td>
                                <td align="left" colspan="1" rowspan="1">0.3176</td>
                                <td align="left" colspan="1" rowspan="1">0.0831</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">
                                    <bold>50.0</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1">6</td>
                                <td align="left" colspan="1" rowspan="1">3</td>
                                <td align="left" colspan="1" rowspan="1">0.50</td>
                                <td align="left" colspan="1" rowspan="1">0.3656</td>
                                <td align="left" colspan="1" rowspan="1">0.1840</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">
                                    <bold>55.0</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1">3</td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">0.333</td>
                                <td align="left" colspan="1" rowspan="1">0.3938</td>
                                <td align="left" colspan="1" rowspan="1">0.2582</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">
                                    <bold>65.0</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1">6</td>
                                <td align="left" colspan="1" rowspan="1">0</td>
                                <td align="left" colspan="1" rowspan="1">0.0</td>
                                <td align="left" colspan="1" rowspan="1">0.4465</td>
                                <td align="left" colspan="1" rowspan="1">0.4523</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">
                                    <bold>80.0</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">0.5171</td>
                                <td align="left" colspan="1" rowspan="1">0.6992</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">
                                    <bold>90.0</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1">4</td>
                                <td align="left" colspan="1" rowspan="1">3</td>
                                <td align="left" colspan="1" rowspan="1">0.75</td>
                                <td align="left" colspan="1" rowspan="1">0.5591</td>
                                <td align="left" colspan="1" rowspan="1">0.8189</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">
                                    <bold>160.0</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1">3</td>
                                <td align="left" colspan="1" rowspan="1">3</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">0.7668</td>
                                <td align="left" colspan="1" rowspan="1">0.999</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">
                                    <bold>210.0</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1">2</td>
                                <td align="left" colspan="1" rowspan="1">2</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">0.8521</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">
                                    <bold>280.0</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">0.9218</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                            </tr>
                        </tbody>
                    </table></alternatives><table-wrap-foot>
                        <fn id="nt101">
                            <label/>
                            <p>The estimated parameters are <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e108" xlink:type="simple"/></inline-formula> for the Exponential model <xref ref-type="bibr" rid="pcbi.1000399-Eisenberg1">[3]</xref> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e109" xlink:type="simple"/></inline-formula> for the Cumulative Dose model.</p>
                        </fn>
                    </table-wrap-foot></table-wrap>
            </sec>
            <sec id="s3c">
                <title>Cryptosporidium</title>
                <p>The cohort for the <italic>Cryptosporidium parvum</italic> study <xref ref-type="bibr" rid="pcbi.1000399-DuPont1">[18]</xref> was
                    35 healthy subjects (12 men and 17 women, age range between 20 and 45 years).
                    The strain was an isolate from a calf and the inoculums were orally administered
                    via capsules. <xref ref-type="fig" rid="pcbi-1000399-g005">Figure 5</xref> and
                        <xref ref-type="table" rid="pcbi-1000399-t002">Table 2</xref> show the fit
                    alongside a fit to the Exponential model (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e110" xlink:type="simple"/></inline-formula>) according to <xref ref-type="bibr" rid="pcbi.1000399-Teunis1">[20]</xref>.</p>
                <fig id="pcbi-1000399-g005" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pcbi.1000399.g005</object-id>
                    <label>Figure 5</label>
                    <caption>
                        <title>Dose-response curves based on the Exponential Model (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e111" xlink:type="simple"/></inline-formula>) and the Cumulative Dose model (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e112" xlink:type="simple"/></inline-formula>) compared to the experimental dataset for
                                <italic>Cryptosporidium parvum</italic> (squares).</title>
                        <p>The estimated parameters are <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e113" xlink:type="simple"/></inline-formula> for the Exponential model [30] and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e114" xlink:type="simple"/></inline-formula> for the Cumulative Dose model.</p>
                    </caption>
                    <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.g005" xlink:type="simple"/>
                </fig>
                <table-wrap id="pcbi-1000399-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000399.t002</object-id><label>Table 2</label><caption>
                        <title>Probability of infection from experimental data for
                                <italic>Cryptosporidium parvum</italic> (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e115" xlink:type="simple"/></inline-formula>) compared to the probability of infection predicted by
                            the Exponential model (EM) and the Cumulative Dose (CD) model.</title>
                    </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pcbi-1000399-t002-2" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.t002" xlink:type="simple"/><table>
                        <colgroup span="1">
                            <col align="left" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                        </colgroup>
                        <thead>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">Dose</td>
                                <td align="left" colspan="1" rowspan="1">No. of subjects</td>
                                <td align="left" colspan="1" rowspan="1">No. Infected</td>
                                <td align="left" colspan="1" rowspan="1">Fraction Infected <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e116" xlink:type="simple"/></inline-formula></td>
                                <td align="left" colspan="1" rowspan="1">
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e117" xlink:type="simple"/></inline-formula>
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e118" xlink:type="simple"/></inline-formula>
                                </td>
                                <td align="left" colspan="1" rowspan="1">
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e119" xlink:type="simple"/></inline-formula>
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e120" xlink:type="simple"/></inline-formula>
                                </td>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">34</td>
                                <td align="left" colspan="1" rowspan="1">5</td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">0.2</td>
                                <td align="left" colspan="1" rowspan="1">0.1273</td>
                                <td align="left" colspan="1" rowspan="1">0.0848</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">108</td>
                                <td align="left" colspan="1" rowspan="1">8</td>
                                <td align="left" colspan="1" rowspan="1">3</td>
                                <td align="left" colspan="1" rowspan="1">0.375</td>
                                <td align="left" colspan="1" rowspan="1">0.3511</td>
                                <td align="left" colspan="1" rowspan="1">0.3173</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">313</td>
                                <td align="left" colspan="1" rowspan="1">3</td>
                                <td align="left" colspan="1" rowspan="1">2</td>
                                <td align="left" colspan="1" rowspan="1">0.6667</td>
                                <td align="left" colspan="1" rowspan="1">0.7145</td>
                                <td align="left" colspan="1" rowspan="1">0.7421</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">504</td>
                                <td align="left" colspan="1" rowspan="1">6</td>
                                <td align="left" colspan="1" rowspan="1">5</td>
                                <td align="left" colspan="1" rowspan="1">0.8333</td>
                                <td align="left" colspan="1" rowspan="1">0.8671</td>
                                <td align="left" colspan="1" rowspan="1">0.9065</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">1129</td>
                                <td align="left" colspan="1" rowspan="1">2</td>
                                <td align="left" colspan="1" rowspan="1">2</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">0.9891</td>
                                <td align="left" colspan="1" rowspan="1">0.9972</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">11460</td>
                                <td align="left" colspan="1" rowspan="1">3</td>
                                <td align="left" colspan="1" rowspan="1">3</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">113900</td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">1139000</td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                            </tr>
                        </tbody>
                    </table></alternatives><table-wrap-foot>
                        <fn id="nt102">
                            <label/>
                            <p>The estimated parameters are <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e121" xlink:type="simple"/></inline-formula> for the Exponential model [30]
                                and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e122" xlink:type="simple"/></inline-formula> for the Cumulative Dose model.</p>
                        </fn>
                    </table-wrap-foot></table-wrap>
            </sec>
            <sec id="s3d">
                <title>Rotavirus</title>
                <p>Finally, we tested the Cumulative Dose model against a dataset for Rotavirus
                        <xref ref-type="bibr" rid="pcbi.1000399-Ward1">[19]</xref>.</p>
                <p>The cohort for rotavirus was 62 adult males, 18 to 45 years old. The inoculation
                    was oral. Unlike the previous dose-response empirical datasets, neither the
                    Cumulative Dose model nor the Exponential model produce a good fit. The
                    Beta-Poisson model (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e123" xlink:type="simple"/></inline-formula>) was statistically a better fit than the Exponential model
                        <xref ref-type="bibr" rid="pcbi.1000399-Teunis1">[20]</xref>.</p>
                <p>Both the Exponential and the Cumulative Dose model increase too rapidly in
                    relation to the probability of infection of 1; i.e. these models cannot maintain
                    a non-zero or non-one probability of infection for a dose range of several
                    orders of magnitude. Conversely, the Beta-Poisson model does not suffer from
                    this limitation since its convergence to 1 is slower, providing a wider range of
                    variance (<xref ref-type="fig" rid="pcbi-1000399-g006">Figure 6</xref> and <xref ref-type="table" rid="pcbi-1000399-t003">Table 3</xref>).</p>
                <fig id="pcbi-1000399-g006" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pcbi.1000399.g006</object-id>
                    <label>Figure 6</label>
                    <caption>
                        <title>Dose-response curves based on the Exponential Model (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e124" xlink:type="simple"/></inline-formula>), the Beta-Poisson model (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e125" xlink:type="simple"/></inline-formula>) and the Cumulative Dose model (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e126" xlink:type="simple"/></inline-formula>) compared to the experimental dataset for Rotavirus
                            (squares).</title>
                        <p>The estimated parameters are <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e127" xlink:type="simple"/></inline-formula> for the Exponential model, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e128" xlink:type="simple"/></inline-formula> for the Beta-Poisson model [31] and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e129" xlink:type="simple"/></inline-formula> for the Cumulative Dose model.</p>
                    </caption>
                    <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.g006" xlink:type="simple"/>
                </fig>
                <table-wrap id="pcbi-1000399-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000399.t003</object-id><label>Table 3</label><caption>
                        <title>Probability of infection from experimental data for Rotavirus (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e130" xlink:type="simple"/></inline-formula>) compared to the the Exponential, Beta-Poisson and
                            Cumulative Dose models.</title>
                    </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pcbi-1000399-t003-3" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.t003" xlink:type="simple"/><table>
                        <colgroup span="1">
                            <col align="left" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                            <col align="center" span="1"/>
                        </colgroup>
                        <thead>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">Dose</td>
                                <td align="left" colspan="1" rowspan="1">No. of subjects</td>
                                <td align="left" colspan="1" rowspan="1">No. Infected</td>
                                <td align="left" colspan="1" rowspan="1">Fraction Infected <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e131" xlink:type="simple"/></inline-formula></td>
                                <td align="left" colspan="1" rowspan="1">
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e132" xlink:type="simple"/></inline-formula>
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e133" xlink:type="simple"/></inline-formula>
                                </td>
                                <td align="left" colspan="1" rowspan="1">
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e134" xlink:type="simple"/></inline-formula>
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e135" xlink:type="simple"/></inline-formula>
                                </td>
                                <td align="left" colspan="1" rowspan="1">
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e136" xlink:type="simple"/></inline-formula>
                                    <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e137" xlink:type="simple"/></inline-formula>
                                </td>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">9×10<sup>−3</sup></td>
                                <td align="left" colspan="1" rowspan="1">5</td>
                                <td align="left" colspan="1" rowspan="1">0</td>
                                <td align="left" colspan="1" rowspan="1">0.0</td>
                                <td align="left" colspan="1" rowspan="1">0.0009</td>
                                <td align="left" colspan="1" rowspan="1">0.0053</td>
                                <td align="left" colspan="1" rowspan="1">&lt;0.001 (*)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">9×10<sup>−2</sup></td>
                                <td align="left" colspan="1" rowspan="1">7</td>
                                <td align="left" colspan="1" rowspan="1">0</td>
                                <td align="left" colspan="1" rowspan="1">0.0</td>
                                <td align="left" colspan="1" rowspan="1">0.009</td>
                                <td align="left" colspan="1" rowspan="1">0.0477</td>
                                <td align="left" colspan="1" rowspan="1">0.0053</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">9×10<sup>−1</sup></td>
                                <td align="left" colspan="1" rowspan="1">7</td>
                                <td align="left" colspan="1" rowspan="1">1</td>
                                <td align="left" colspan="1" rowspan="1">0.1428</td>
                                <td align="left" colspan="1" rowspan="1">0.0861</td>
                                <td align="left" colspan="1" rowspan="1">0.2509</td>
                                <td align="left" colspan="1" rowspan="1">0.0740</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">9</td>
                                <td align="left" colspan="1" rowspan="1">11</td>
                                <td align="left" colspan="1" rowspan="1">8</td>
                                <td align="left" colspan="1" rowspan="1">0.7273</td>
                                <td align="left" colspan="1" rowspan="1">0.5934</td>
                                <td align="left" colspan="1" rowspan="1">0.5442</td>
                                <td align="left" colspan="1" rowspan="1">0.6175</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">9×10<sup>1</sup></td>
                                <td align="left" colspan="1" rowspan="1">7</td>
                                <td align="left" colspan="1" rowspan="1">6</td>
                                <td align="left" colspan="1" rowspan="1">0.8571</td>
                                <td align="left" colspan="1" rowspan="1">0.9999</td>
                                <td align="left" colspan="1" rowspan="1">0.7428</td>
                                <td align="left" colspan="1" rowspan="1">0.9999</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">9×10<sup>2</sup></td>
                                <td align="left" colspan="1" rowspan="1">8</td>
                                <td align="left" colspan="1" rowspan="1">7</td>
                                <td align="left" colspan="1" rowspan="1">0.875</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">0.8562</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">9×10<sup>3</sup></td>
                                <td align="left" colspan="1" rowspan="1">7</td>
                                <td align="left" colspan="1" rowspan="1">5</td>
                                <td align="left" colspan="1" rowspan="1">0.7143</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">0.9197</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">9×10<sup>4</sup></td>
                                <td align="left" colspan="1" rowspan="1">3</td>
                                <td align="left" colspan="1" rowspan="1">3</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                                <td align="left" colspan="1" rowspan="1">0.9551</td>
                                <td align="left" colspan="1" rowspan="1">1.0</td>
                            </tr>
                        </tbody>
                    </table></alternatives><table-wrap-foot>
                        <fn id="nt103">
                            <label/>
                            <p>The estimated parameters are <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e138" xlink:type="simple"/></inline-formula> for the Exponential model, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e139" xlink:type="simple"/></inline-formula> for the Beta-Poisson model [31]
                                and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e140" xlink:type="simple"/></inline-formula> for the Cumulative Dose model. (*) The
                                dose in the original trial was administered in concentrations, to
                                work with discrete pathogens as required by the Cumulative Dose
                                model, we assumed that the concentration of
                                    9×10<sup>−2</sup> is equivalent to 9
                                pathogens. As a consequence the concentration of
                                    9×10<sup>−3</sup> could not be tested since
                                it is a fraction of a pathogen. The probability of infection for a
                                single pathogen is 10<sup>−3</sup>. This assumption is
                                only required by the Cumulative Dose model.</p>
                        </fn>
                    </table-wrap-foot></table-wrap>
                <p>A possible explanation of the poor fit of the Cumulative Dose model is the high
                    degree of acquired immunity to Rotavirus and the changing serotype profile
                    circulating within populations <xref ref-type="bibr" rid="pcbi.1000399-Koopman1">[23]</xref>. Unlike the polio virus study, the rotavirus
                    cohort consisting of adults (18–45 years old), is likely to have been
                    exposed multiple times to various rotavirus serotypes <xref ref-type="bibr" rid="pcbi.1000399-Koopman2">[24]</xref>. Such
                    heterogeneity in susceptibility flattens out dose response curves beyond what
                    can be captured by exponential dose response models or this Cumulative Dose
                    response model.</p>
            </sec>
            <sec id="s3e">
                <title>The Effect of Temporal Exposure Length</title>
                <p>In the previous subsections we fixed temporal exposure length, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e141" xlink:type="simple"/></inline-formula>, to 1 hour, and assume that this is the time corresponding to
                    the single shot inoculation, analogous to existing experimental dose-response
                    trials. In this section, we present simulations for a range of different
                    temporal exposure lengths, illustrating how longer times affect the dose
                    response curve. The model is set to the parameters that provided an optimal fit
                    for a temporal exposure length of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e142" xlink:type="simple"/></inline-formula>.</p>
                <p><xref ref-type="fig" rid="pcbi-1000399-g007">Figure 7</xref> shows the
                    dose-response curves for Poliovirus type 1 for different lengths of exposure for
                    the estimated parameters used in <xref ref-type="fig" rid="pcbi-1000399-g004">Figure 4</xref> to fit the experimental data for the condition
                    T<sub>e</sub> = 1.0: <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e143" xlink:type="simple"/></inline-formula>. As the exposure length increases, the probability of
                    infection decreases dramatically. Therefore, assuming that the unit of time is
                    one hour, and this is the equivalent for a dose that is administered in a single
                    shot, the probability of infection generated by the Cumulative Dose model for a
                    dose of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e144" xlink:type="simple"/></inline-formula> of 90 pathogens administered in one hour is 0.82. If the dose
                    were administered not in one hour, but uniformly over ten hours the probability
                    of infection would be 0.18. If the dose were administered over fifty hours the
                    probability of infection would be reduced to 0.0001. To obtain the same
                    probability of infection for a ten hours inoculation period instead of one, we
                    would require a dose of 139 pathogens instead of 90.</p>
                <fig id="pcbi-1000399-g007" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pcbi.1000399.g007</object-id>
                    <label>Figure 7</label>
                    <caption>
                        <title>Predicted effects of varying exposure times (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e145" xlink:type="simple"/></inline-formula>) when inoculated with Poliovirus type 1.</title>
                        <p>Parameters are defined as stated in <xref ref-type="fig" rid="pcbi-1000399-g004">Figure 4</xref>.</p>
                    </caption>
                    <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.g007" xlink:type="simple"/>
                </fig>
                <p>Because data on the impact of temporal patterns of inoculation are currently not
                    available, a model with dose-time dependence such as ours is not identifiable
                        <xref ref-type="bibr" rid="pcbi.1000399-Armitage1">[25]</xref>; i.e., the model can be fit to existing single
                    dose empirical data with many different parameters sets. For example, in <xref ref-type="fig" rid="pcbi-1000399-g008">Figure 8</xref> we show model
                    simulation results for <italic>Cryptosporidium parvum</italic> for two different
                    parameter sets. Both parameters sets have a similar fit to the
                        <italic>Cryptosporidium parvum</italic> dataset when <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e146" xlink:type="simple"/></inline-formula> (mean square error using <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e147" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e148" xlink:type="simple"/></inline-formula> is 3.5×10<sup>−3</sup> and
                        9.7×10<sup>−3</sup> respectively). For values of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e149" xlink:type="simple"/></inline-formula>, however, the dose response relationships of the two parameter
                    sets diverge. Parameter set <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e150" xlink:type="simple"/></inline-formula> is much less sensitive to exposure time than <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e151" xlink:type="simple"/></inline-formula> due its slower dynamics. Using parameter set R, pathogens
                    proliferate faster, are being eliminated by each immune effector more quickly,
                    are recruiting fewer immune effectors, and are eliminating immune effectors at a
                    slower rate. On the other hand, using parameter set R, the natural rate of
                    turnover of immune effectors is more rapid. We cannot argue at this point which
                    is the most plausible configuration since identifiability cannot be resolved
                    without data from dosing trials for different exposure lengths.</p>
                <fig id="pcbi-1000399-g008" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pcbi.1000399.g008</object-id>
                    <label>Figure 8</label>
                    <caption>
                        <title>Predicted effects of varying exposure times (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e152" xlink:type="simple"/></inline-formula>) when inoculated with <italic>Cryptosporidium
                            parvum</italic>.</title>
                        <p>The top graph comes from simulations using the parameter set defined in
                                <xref ref-type="fig" rid="pcbi-1000399-g005">Figure 5</xref>. The
                            bottom graph comes simulations using the parameter set <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e153" xlink:type="simple"/></inline-formula>.</p>
                    </caption>
                    <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.g008" xlink:type="simple"/>
                </fig>
            </sec>
            <sec id="s3f">
                <title>The Effect of Dosing Patterns over the Exposure Window</title>
                <p>In this section we relax the assumption that pathogens are inoculated at a fixed
                    rate. We allow variation both in dose magnitude and length of exposure time, in
                    order to capture a more realistic exposure scenario.</p>
                <p>The temporal pattern of inoculation of pathogens within a host depends both on
                    the behavior of the host and the contamination of the environment the host
                    interacts with. For instance, a susceptible host in a venue contaminated with
                    influenza will be exposed to pathogens from air and fomites. However, the
                    temporal patterns of exposure for these two modes of transmission are different.
                    The host is likely to receive a small dose with every breath when breathing
                    contaminated air. In fomite mediated transmission, however, the touching of a
                    mucous membrane with contaminated fingers, for example, is likely to transmit a
                    larger but less frequent dose.</p>
                <p>To illustrate this effect we devised an experiment where both the total
                    inoculated dose <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e154" xlink:type="simple"/></inline-formula> and the exposure time length <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e155" xlink:type="simple"/></inline-formula> are fixed. The only parameter that varies is the number of
                    inoculation events, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e156" xlink:type="simple"/></inline-formula>, which ranges from 1 to the total dose <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e157" xlink:type="simple"/></inline-formula>. Consequently, once the number of inoculations events is
                    determined, the dose inoculated in each event is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e158" xlink:type="simple"/></inline-formula> and the rate at which inoculation occur is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e159" xlink:type="simple"/></inline-formula>.</p>
                <p><xref ref-type="fig" rid="pcbi-1000399-g009">Figure 9</xref> shows the results of
                    this experiment where the same parameter sets are used as in <xref ref-type="fig" rid="pcbi-1000399-g008">Figure 8</xref>. The pathogen is
                        <italic>Cryptosporidium parvum</italic>, and the same two different
                    parameters sets, <italic>S</italic> and <italic>R</italic>, are used to inform
                    the cumulative dose model. The total dose inoculated is set to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e160" xlink:type="simple"/></inline-formula> and the temporal exposure length is set to
                        <italic>T<sub>e</sub></italic> = 120.0
                    hours.</p>
                <fig id="pcbi-1000399-g009" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pcbi.1000399.g009</object-id>
                    <label>Figure 9</label>
                    <caption>
                        <title>Predicted effects of different temporal patterns of exposure when
                            inoculated with <italic>Cryptosporidium parvum</italic>.</title>
                        <p>The main figure displays the probability of infection as function of the
                            number of inoculation events. The line with circular markers comes from
                            simulation results using the parameter set defined in <xref ref-type="fig" rid="pcbi-1000399-g005">Figure 5</xref>, and the line
                            with square markers comes from simulation results using the parameter
                            set <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000399.e161" xlink:type="simple"/></inline-formula> The insets below demonstrate three temporal patterns
                            for three different patterns of inoculation events:
                            A = 1,
                            B = 4 and
                            C = 50 events respectively. The solid
                            line represents one instance of the 5000 replicas used in the
                            experiment. The dashed line represents the average of dose inoculated
                            over time.</p>
                    </caption>
                    <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000399.g009" xlink:type="simple"/>
                </fig>
                <p>For both parameter sets S and R we observe the same behavior: infectivity
                    decreases as the frequency or number of inoculations events increases. The
                    temporal pattern more likely to be associated with fomite transmission (low
                    frequency and high dose, <xref ref-type="fig" rid="pcbi-1000399-g009">Figure
                    9.B</xref>) is more likely to produce infection than the patterns associated
                    with airborne transmission (high-frequency and low dose, <xref ref-type="fig" rid="pcbi-1000399-g009">Figure 9.C</xref>) .</p>
                <p>For parameter set <italic>R</italic>, the probability of infection if the dose is
                    inoculated with a single exposure (<xref ref-type="fig" rid="pcbi-1000399-g009">Figure 9.A</xref>) is 0.752. The same dose inoculated over 4 events, where
                    each event is one fourth of the total dose (<xref ref-type="fig" rid="pcbi-1000399-g009">Figure 9.B</xref>), reduces the probability of
                    infection to 0.443. In addition, if the dose is inoculated over 50 events (<xref ref-type="fig" rid="pcbi-1000399-g009">Figure 9.C</xref>) the probability
                    decreases to 0.111. For parameter set <italic>S</italic>, the reduction of the
                    infection probability is less pronounced: 0.740, 0.676 and 0.601 for 1, 4 and 50
                    inoculation events respectively.</p>
                <p>In previous sections we showed that longer temporal exposure lengths decrease
                    infectivity due to the action of the immune system. In this section, we show
                    that not only the duration of the exposure matters, but also the way in which
                    pathogens arrive within that interval can decrease infectivity. These results
                    suggest that risk assessments based on current dose-response data might be
                    over-estimating risk of infection. An important corollary is that risk of
                    infection for a given exposure dose may depend on the route of transmission
                    based on their differences in the pattern of exposure.</p>
            </sec>
        </sec>
        <sec id="s4">
            <title>Discussion</title>
            <p>We examined a dynamic mechanistic model where immune system effects generated dose
                response dependence on the timing of doses. The specific aspects of our model that
                generate these dose-timing effects are: 1) decreases in available immune effectors
                because they are being eliminated as they kill pathogens; and 2) increases in
                available immune effectors due to both pathogen dependent and independent
                recruitment. An additional mechanism resulting in decreases in available immune
                effectors that is not included in our model could be the time of immune effector
                engagement with pathogens in the killing process. The dose-timing effects we
                illustrate would be absent in a model where some effector like a T-cell
                instantaneously kills pathogens or pathogen generating cells, where no killing
                capacity is lost with each kill, and where effector dynamics are not otherwise
                altered by encounters with pathogens. Any such model, however, is highly
                unrealistic, and therefore we conclude that the dose-timing effects presented in our
                model could be important and warrant further study.</p>
            <p>Dose-timing effects have implications for microbial risk assessment, for infection
                transmission system modeling, and for the evolution of emerging pathogens.
                Considering a microbial risk assessment example, the implications of our findings
                suggest that exposure routes with different dose-timing dynamics could have
                different risks and therefore result in different clean up protocols for
                contamination events such as a norovirus outbreak or a Katrina-like disaster. Dose
                timing could, therefore, affect decisions on which venues to close or what the total
                dose that workers would be permitted to accrue during a cleanup operation.</p>
            <p>Considering modeling infection transmission, the standard approach is to define a
                contact and a transmission probability per contact while the physical route of
                transmission is ignored. Modeling the physical route of transmission is important
                when it is necessary to specify how much transmission is taking place in particular
                public venues and when specifying which control actions in these venues will reduce
                transmission. When different routes have different temporal exposure patterns, we
                demonstrate here that there is considerable potential for immune system effects to
                alter the ratio by which airborne transmitted and hand-fomite transmitted pathogens
                generate new infections. If we had data on infection risks under different
                dose-timing patterns, we could say more precisely how much difference in risk there
                might be from an airborne and a hand-fomite mediated pathogen. Unfortunately such
                data is lacking.</p>
            <p>The evolution of emerging infection implications derive from the route of
                transmission effects just discussed. When pathogens first jump species, they are
                likely to encounter strong innate immune responses to which they must evolve some
                escape strategy. That means very high transmission doses will be required to sustain
                transmission and that low dose exposure over longer times such as occurs with
                airborne transmission will be the most unlikely to be effective in transmitting
                infection. But, as escape from innate immune responses evolves, the balance could
                begin to favor airborne transmission which might be more effective in disseminating
                infection.</p>
            <p>We do not have enough dose timing data for any infection to evaluate either the
                microbial risk assessment implications, the infection transmission system
                implications, or the emerging infection evolution implications. Any data providing
                indications of the magnitude of dose-timing effects generated by any type of
                immunity to any agent would provide an important first step that would at least
                indicate what range of effects might be expected. Animal studies could compare the
                risks associated with a single instantaneously delivered dose with the same dose
                magnitude delivered over extended periods of time. Measurements of specific immune
                effector dynamics, such as interferon gamma <xref ref-type="bibr" rid="pcbi.1000399-Howat1">[26]</xref> would improve our
                mechanistic understanding of a cumulative dose effect and indicate how to refine our
                models for different animal/pathogen systems.</p>
            <p>The issue of dose-response trial design is crucial for advancing both quantitative
                microbial risk assessment and analysis of population infection transmission systems.
                Due to the absence of a prior theoretical framework, there has been no motivation to
                conduct dosing trials that take multiple doses and multiple dosing times into
                account. Now that the potential effects of dose timing have been demonstrated and
                the practical significance of such measurements for microbial risk assessment and
                transmission system analyses is more evident, we hope to see such experiments.</p>
        </sec>
    </body>
    <back>
        <ack>
            <p>We thank John Coffin, Igor Rouzine, and Patrick Nelson for their valuable comments on
                early versions of this paper.</p>
        </ack>
        <ref-list>
            <title>References</title>
            <ref id="pcbi.1000399-Haas1">
                <label>1</label>
                <element-citation publication-type="other" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Haas</surname>
                            <given-names>CN</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Rose</surname>
                            <given-names>JB</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Gerba</surname>
                            <given-names>CP</given-names>
                        </name>
                    </person-group>
                    <year>1999</year>
                    <source>Quantitative Microbial Risk Assessment</source>
                    <publisher-loc>New York</publisher-loc>
                    <publisher-name>John Wiley &amp; Sons, Inc., ISBN:
                    0-471-18397-0</publisher-name>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Noakes1">
                <label>2</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Noakes</surname>
                            <given-names>CJ</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Beggs</surname>
                            <given-names>CB</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Sleigh</surname>
                            <given-names>PA</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Kerr</surname>
                            <given-names>KG</given-names>
                        </name>
                    </person-group>
                    <year>2006</year>
                    <article-title>Modelling the transmission of airborne infection in enclosed
                        spaces.</article-title>
                    <source>Epidemiology and Infection</source>
                    <volume>134(5)</volume>
                    <fpage>1082</fpage>
                    <lpage>91</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Eisenberg1">
                <label>3</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Eisenberg</surname>
                            <given-names>JNS</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Lei</surname>
                            <given-names>X</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Hubbard</surname>
                            <given-names>AH</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Brookhart</surname>
                            <given-names>MA</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Colford</surname>
                            <given-names>JM</given-names>
                            <suffix>Jr</suffix>
                        </name>
                    </person-group>
                    <year>2005</year>
                    <article-title>The role of disease transmission and conferred immunity in
                        outbreaks: Analysis of the 1993 Cryptosporidium outbreak in Milwaukee.</article-title>
                    <source>American Journal of Epidemiology</source>
                    <fpage>62</fpage>
                    <lpage>72</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Atkinson1">
                <label>4</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Atkinson</surname>
                            <given-names>MP</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Wein</surname>
                            <given-names>LM</given-names>
                        </name>
                    </person-group>
                    <year>2008</year>
                    <article-title>Quantifying the routes of transmission for pandemic influenza.</article-title>
                    <source>Bull Math Biol</source>
                    <volume>70</volume>
                    <fpage>820</fpage>
                    <lpage>867</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Ellenberger1">
                <label>5</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Ellenberger</surname>
                            <given-names>D</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2006</year>
                    <article-title>HIV-1 DNA/MVA vaccination reduces the per exposure probability of
                        infection during repeated mucosal SHIV challenges.</article-title>
                    <source>Virology</source>
                    <volume>352</volume>
                    <fpage>216</fpage>
                    <lpage>225</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-GarciaLerma1">
                <label>6</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Garcia-Lerma</surname>
                            <given-names>JG</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2008</year>
                    <article-title>Prevention of rectal SHIV transmission in macaques by daily or
                        intermittent prophylaxis with emtricitabine and tenofovir.</article-title>
                    <source>PLoS Med</source>
                    <volume>5</volume>
                    <fpage>e28</fpage>
                    <comment>doi:10.1371/journal.pmed.0050028</comment>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Tuckwell1">
                <label>7</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Tuckwell</surname>
                            <given-names>HC</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Shipman</surname>
                            <given-names>PD</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Perelson</surname>
                            <given-names>AS</given-names>
                        </name>
                    </person-group>
                    <year>2008</year>
                    <article-title>The probability of HIV infection in a new host and its reduction
                        with microbicides.</article-title>
                    <source>Math Biosci</source>
                    <volume>214</volume>
                    <fpage>81</fpage>
                    <lpage>86</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-VanRompay1">
                <label>8</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Van Rompay</surname>
                            <given-names>KK</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Kearney</surname>
                            <given-names>BP</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Sexton</surname>
                            <given-names>JJ</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Colon</surname>
                            <given-names>R</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Lawson</surname>
                            <given-names>JR</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Blackwood</surname>
                            <given-names>EJ</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Lee</surname>
                            <given-names>WA</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Bischofberger</surname>
                            <given-names>N</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Marthas</surname>
                            <given-names>ML</given-names>
                        </name>
                    </person-group>
                    <year>2006</year>
                    <article-title>Evaluation of oral tenofovir disoproxil fumarate and topical
                        tenofovir GS-7340 to protect infant macaques against repeated oral
                        challenges with virulent simian immunodeficiency virus.</article-title>
                    <source>J Acquir Immune Defic Syndr</source>
                    <volume>43</volume>
                    <fpage>6</fpage>
                    <lpage>14</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-VanRompay2">
                <label>9</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Van Rompay</surname>
                            <given-names>KK</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2005</year>
                    <article-title>Attenuated poxvirus-based simian immunodeficiency virus (SIV)
                        vaccines given in infancy partially protect infant and juvenile macaques
                        against repeated oral challenge with virulent SIV.</article-title>
                    <source>J Acquir Immune Defic Syndr</source>
                    <volume>38</volume>
                    <fpage>124</fpage>
                    <lpage>134</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Wilson1">
                <label>10</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Wilson</surname>
                            <given-names>NA</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2006</year>
                    <article-title>Vaccine-induced cellular immune responses reduce plasma viral
                        concentrations after repeated low-dose challenge with pathogenic simian
                        immunodeficiency virus SIVmac239.</article-title>
                    <source>J Virol</source>
                    <volume>80</volume>
                    <fpage>5875</fpage>
                    <lpage>5885</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Brachman1">
                <label>11</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Brachman</surname>
                            <given-names>PS</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Kaufman</surname>
                            <given-names>AF</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Dalldorf</surname>
                            <given-names>FG</given-names>
                        </name>
                    </person-group>
                    <year>1966</year>
                    <article-title>Industrial inhalation Anthrax.</article-title>
                    <source>Bacteriol Rev</source>
                    <volume>30</volume>
                    <fpage>646</fpage>
                    <lpage>659</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Rand1">
                <label>12</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Rand</surname>
                            <given-names>DA</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Wilson</surname>
                            <given-names>HB</given-names>
                        </name>
                    </person-group>
                    <year>1991</year>
                    <article-title>Chaotic stochasticity: a ubiquitous source of unpredictability in
                        epidemics.</article-title>
                    <source>Proc Royal Society B</source>
                    <volume>246</volume>
                    <fpage>179</fpage>
                    <lpage>184</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-McKane1">
                <label>13</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>McKane</surname>
                            <given-names>AJ</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Newman</surname>
                            <given-names>TJ</given-names>
                        </name>
                    </person-group>
                    <year>2005</year>
                    <article-title>Predator-prey cycles from resonant amplification of demographic
                        stochasticity.</article-title>
                    <source>Physical Review Letters</source>
                    <volume>94</volume>
                    <fpage>218</fpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Alonso1">
                <label>14</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Alonso</surname>
                            <given-names>D</given-names>
                        </name>
                        <name name-style="western">
                            <surname>McKane</surname>
                            <given-names>AJ</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Pascual</surname>
                            <given-names>M</given-names>
                        </name>
                    </person-group>
                    <year>2006</year>
                    <article-title>Stochastic amplification in epidemics.</article-title>
                    <source>J R Soc Interface</source>
                    <comment>10.1098/rsif.2006.0192</comment>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Gillespie1">
                <label>15</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Gillespie</surname>
                            <given-names>DT</given-names>
                        </name>
                    </person-group>
                    <year>1976</year>
                    <article-title>A general method for numerically simulating the stochastic time
                        evolution of coupled chemical reactions.</article-title>
                    <source>Journal of Computational Physics</source>
                    <volume>22</volume>
                    <fpage>403</fpage>
                    <lpage>434</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-vanKampen1">
                <label>16</label>
                <element-citation publication-type="other" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>van Kampen</surname>
                            <given-names>NG</given-names>
                        </name>
                    </person-group>
                    <year>1992</year>
                    <source>Stochastic processes in physics and chemistry</source>
                    <publisher-loc>Amsterdam</publisher-loc>
                    <publisher-name>Elsevier</publisher-name>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Minor1">
                <label>17</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Minor</surname>
                            <given-names>TE</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Allen</surname>
                            <given-names>CI</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Tsiatis</surname>
                            <given-names>AA</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Nelson</surname>
                            <given-names>DB</given-names>
                        </name>
                        <name name-style="western">
                            <surname>d'Alesio</surname>
                            <given-names>DJ</given-names>
                        </name>
                    </person-group>
                    <year>1981</year>
                    <article-title>Human infective dose determinations for oral poliovirus type 1
                        vaccine in infants.</article-title>
                    <source>Journal of Clinical Microbiology</source>
                    <volume>13(2)</volume>
                    <fpage>388</fpage>
                    <lpage>389</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-DuPont1">
                <label>18</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>DuPont</surname>
                            <given-names>HL</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Chappell</surname>
                            <given-names>CL</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Sterling</surname>
                            <given-names>CR</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Okhuysen</surname>
                            <given-names>PC</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Rose</surname>
                            <given-names>JB</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Jakubowski</surname>
                            <given-names>W</given-names>
                        </name>
                    </person-group>
                    <year>1995</year>
                    <article-title>The infectivity of Cryptosporidium parvum in healthy workers.</article-title>
                    <source>The New England Journal of Medicine</source>
                    <volume>332(13)</volume>
                    <fpage>855</fpage>
                    <lpage>859</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Ward1">
                <label>19</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Ward</surname>
                            <given-names>RL</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Bernstein</surname>
                            <given-names>DI</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Young</surname>
                            <given-names>EC</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Sherwood</surname>
                            <given-names>JR</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Knowlton</surname>
                            <given-names>DR</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Schiff</surname>
                            <given-names>GM</given-names>
                        </name>
                    </person-group>
                    <year>1986</year>
                    <article-title>Human Rotavirus studies in volunteers: determination of
                        infectious dose and serological response to infection.</article-title>
                    <source>Journal of Infectious Diseases</source>
                    <volume>154(5)</volume>
                    <fpage>871</fpage>
                    <lpage>880</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Teunis1">
                <label>20</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Teunis</surname>
                            <given-names>PFM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>van der Heijden</surname>
                            <given-names>OG</given-names>
                        </name>
                        <name name-style="western">
                            <surname>van der Giessen</surname>
                            <given-names>JWB</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Havelaar</surname>
                            <given-names>AH</given-names>
                        </name>
                    </person-group>
                    <year>1996</year>
                    <article-title>The dose-response relation in human volunteers for
                        gastro-intestinal pathogens.</article-title>
                    <source>Rijksinstituut voor Volksgezondheid en Milieu Bilthoven</source>
                    <volume>284550002</volume>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Haas2">
                <label>21</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Haas</surname>
                            <given-names>CN</given-names>
                        </name>
                    </person-group>
                    <year>1983</year>
                    <article-title>Estimation of risk due to low doses of microorganisms: a
                        comparison of alternative methodologies.</article-title>
                    <source>American Journal of Epidemiology</source>
                    <volume>118(4)</volume>
                    <fpage>1097</fpage>
                    <lpage>1100</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Holland1">
                <label>22</label>
                <element-citation publication-type="other" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Holland</surname>
                            <given-names>JH</given-names>
                        </name>
                    </person-group>
                    <year>1975</year>
                    <source>Adaptation in Natural and Artificial Systems</source>
                    <publisher-loc>Ann Arbor</publisher-loc>
                    <publisher-name>University of Michigan Press</publisher-name>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Koopman1">
                <label>23</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Koopman</surname>
                            <given-names>JS</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Monto</surname>
                            <given-names>AS</given-names>
                        </name>
                    </person-group>
                    <year>1989</year>
                    <article-title>The Tecumseh Study XV: Rotavirus infection and pathogenicity.</article-title>
                    <source>American Journal of Epidemiology</source>
                    <volume>130(4)</volume>
                    <fpage>750</fpage>
                    <lpage>759</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Koopman2">
                <label>24</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Koopman</surname>
                            <given-names>JS</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Monto</surname>
                            <given-names>AS</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Longini</surname>
                            <given-names>IM</given-names>
                        </name>
                    </person-group>
                    <year>1989</year>
                    <article-title>The Tecumseh Study XVI: Family and community sources of rotavirus
                        infection.</article-title>
                    <source>Am J Epidemiol</source>
                    <volume>130(4)</volume>
                    <fpage>760</fpage>
                    <lpage>768</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Armitage1">
                <label>25</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Armitage</surname>
                            <given-names>P</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Spicer</surname>
                            <given-names>CC</given-names>
                        </name>
                    </person-group>
                    <year>1956</year>
                    <article-title>The detection of variation in host susceptibility in dilution
                        counting experiments.</article-title>
                    <source>Journal of Hygiene</source>
                    <volume>54</volume>
                    <fpage>401</fpage>
                    <lpage>414</lpage>
                </element-citation>
            </ref>
            <ref id="pcbi.1000399-Howat1">
                <label>26</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Howat</surname>
                            <given-names>TJ</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Barreca</surname>
                            <given-names>C</given-names>
                        </name>
                        <name name-style="western">
                            <surname>O'Hare</surname>
                            <given-names>P</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Gog</surname>
                            <given-names>JR</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Grenfell</surname>
                            <given-names>TB</given-names>
                        </name>
                    </person-group>
                    <year>2006</year>
                    <article-title>Modelling dynamics of the type I interferon response to in vitro
                        viral infection.</article-title>
                    <source>J R Soc Interface</source>
                    <volume>3</volume>
                    <fpage>699</fpage>
                    <lpage>709</lpage>
                </element-citation>
            </ref>
        </ref-list>
        
    </back>
</article>